RESUMEN
BACKGROUND: Many new variants are constantly detected by capillary electrophoresis (CE) and high-performance liquid chromatography (HPLC). Here, we described a novel α-globin gene mutation. METHODS: The proband was a 46-year-old male who came to the hospital with his wife for pre-conception thalassemia screening. Hematological parameters were obtained from a complete blood count. Hb analysis was performed by CE and HPLC. Routine genetic analysis was carried out by Gap-polymerase chain reaction (Gap-PCR) and PCR and reverse dot-blot (PCR-RDB). Sanger sequencing was used to identify the hemoglobin variant. RESULTS: An abnormal Hb variant was observed at electrophoretic zone 5 and zone 1 on the CE program. HPLC showed a peak of abnormal Hb in the S window. No mutations were detected by Gap-PCR and PCR-RDB. Sanger sequencing revealed an AAC>AAA mutation at codon 78 of the α-globin gene [α1 78 (EF7) AsnâLys (AAC> AAA); HBA1:c.237C>A]. The pedigree study demonstrated that the Hb variant was inherited from his mother. CONCLUSIONS: It is the first report about the variant, so we named it Hb Qinzhou for the place of origin of the proband. Hb Qinzhou presents a normal hematological phenotype.
Asunto(s)
Hemoglobinas Anormales , Talasemia alfa , Humanos , Masculino , Globinas alfa/genética , Globinas alfa/análisis , Talasemia alfa/diagnóstico , Talasemia alfa/genética , Pueblos del Este de Asia , Hemoglobina Glucada/genética , Hemoglobinas Anormales/genética , Hemoglobinas Anormales/análisis , Mutación , Persona de Mediana EdadRESUMEN
AIM: ß2-Microglobulin (ß2-MG) and α1-microglobulin (α1-MG) have molecular weights of 11,800 and 33,000 Da, respectively. We studied the α1-MG and ß2-MG reduction ratios (RRs) and survival in patients on predilution online haemodiafiltration (Pre-OL-HDF). METHODS: Participants were 247 Pre-OL-HDF patients. α1-MG and ß2-MG RRs were assessed at baseline. Kaplan-Meier survival and Cox proportional hazard analyses were used. RESULTS: In 247 patients, the median age was 67 (56-73) years, the dialysis duration was 77 (46-150) months, and the diabetes prevalence was 47.4%. Twenty-two patients died over the 450-day study period. The mortality cut-off values using receiver-operating characteristic curves for the α1-MG and ß2-MG RRs were 20% and 80%, respectively. Survival rates were significantly (p < 0.05) higher in patients with α1-MG RRs ≥20% (n = 134) compared with patients with α1-MG RRs <20% (n = 113) and in patients with ß2-MG RRs ≥80% (n = 87) compared with patients with ß2-MG RRs <80% (n = 160). Cox models adjusting for diabetes and dialysis duration showed that α1-MG RR, ß2-MG RR, and pre- and postdialysis ß2-MG were risk factors for all-cause mortality; however, after additional adjustment for age, sex, and serum albumin, only ß2-MG RR and pre- and postdialysis ß2-MG were significant predictors of mortality (p < 0.05). α1-MG RRs were significantly correlated with ß2-MG RRs (ρ = 0.73, p < 0.0001) and serum albumin levels (ρ = 0.13, p < 0.05). CONCLUSION: In patients on Pre-OL-HDF, α1-MG RRs ≥20% and ß2-MG RRs ≥80% were associated with better survival, ß2-MG RR ≥80% and pre-and postdialysis ß2-MG levels were significant predictors of all-cause mortality, and α1-MG RR ≥20% may predict mortality.
Asunto(s)
Hemodiafiltración , Anciano , Humanos , Microglobulina beta-2/análisis , Hemodiafiltración/efectos adversos , Estudios Prospectivos , Diálisis Renal , Albúmina Sérica , Persona de Mediana Edad , Globinas alfa/análisisRESUMEN
We report the identification of a novel hemoglobin (Hb) variant [α57(E6)GlyâCys; HBA1: c.172G>T], to be referred to as Hb Kirikiriroa. The variant was detected in five subjects from two families, with familial relationship established between the families following diagnosis. A persistently elevated Hb A1c over a 1-year period prompted hemoglobinopathy screening in an adolescent male of New Zealand (NZ) European descent (case 1). Capillary electrophoresis (CE) revealed the variant was negatively charged and susceptible to oxidation, with multiple abnormal peaks detected (0.4-5.1% total Hb). Hb A1c analysis by cation exchange high performance liquid chromatography (HPLC) was the first indication of the variant in a pregnant female of NZ European descent (case 2). Cases 1 and 2 had normal complete blood counts. Isopropanol stability testing provided evidence the variant was unstable. We herein describe the characterization of Hb Kirikiriroa and clinical significance of the variant for interference with Hb A1c analysis by CE and cation exchange HPLC.
Asunto(s)
Hemoglobinas Anormales , Globinas alfa , 2-Propanol , Adolescente , Cromatografía Líquida de Alta Presión/métodos , Femenino , Hemoglobina Glucada/análisis , Hemoglobina Glucada/genética , Hemoglobinas Anormales/análisis , Hemoglobinas Anormales/genética , Humanos , Masculino , Mutación , Embarazo , Globinas alfa/análisis , Globinas alfa/genéticaRESUMEN
Here we report a new α chain variant accidentally discovered during Hb A1c measurement by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) that revealed the presence of a variant α chain with a mass of 15155 Da. However, this hemoglobin (Hb) variant cannot be detected by the first-line methods such as cation exchange high performance liquid chromatography (HPLC) and capillary electrophoresis (CE). Sanger sequencing confirmed the presence of a heterozygous missense mutation [HBA2: c.46G>A, codon 15 (GGT>AGT), (GlyâSer)]. The theoretical mass difference (30 Da) due to the substitution of amino acid glycine to serine matched the actual measured mass difference (29 Da). As this is the first report of the mutation, we named it Hb Nanchang after the place of residence of the proband.
Asunto(s)
Hemoglobinas Anormales , Globinas alfa , Codón , Glicina/genética , Hemoglobinas Anormales/análisis , Humanos , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Globinas alfa/análisis , Globinas alfa/genéticaRESUMEN
We here describe a novel hemoglobin (Hb) variant, Hb Liaobu [α107(G14)ValâLeu, HBA2: c.322G>C], in a Chinese family. The structurally abnormal α chain variant could not be detected using capillary electrophoresis (CE) and was subsequently characterized by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS), and further confirmed by reversed phase high performance liquid chromatography (HPLC). Sanger sequencing revealed a novel base mutation on the α2-globin gene and RNA analysis by reverse transcription polymerase chain reaction (RT-PCR) showed the presence of an abnormal HBA transcript. The isopropanol stability test indicated the stable state of this structural Hb variant. In conclusion, a new Hb variant, Hb Liaobu, was discovered and characterized. It was proven to be a nonpathogenic variant. Our study resolved the confusion in the clinical diagnosis of individuals with this novel Hb variant in this family.
Asunto(s)
Hemoglobinas Anormales , Electroforesis Capilar , Hemoglobinas Anormales/análisis , Hemoglobinas Anormales/genética , Humanos , Rayos Láser , Espectrometría de Masas , Mutación , Globinas alfa/análisis , Globinas alfa/genéticaAsunto(s)
Eritroblastos/ultraestructura , Eritrocitos/ultraestructura , Cuerpos de Inclusión/química , Globinas alfa/análisis , Niño , Femenino , Hemoglobina Fetal/análisis , Hemoglobinopatías/sangre , Hemoglobinopatías/genética , Heterocigoto , Humanos , Esplenectomía , Adulto Joven , Talasemia beta/sangre , Talasemia beta/genética , Talasemia beta/cirugíaRESUMEN
Hb H disease is a moderate to severe form of α-thalassemia (α-thal). Patients with Hb H disease may become symptomatic, especially during infections and pregnancy, and may require transfusions. Herein, we present a 16-year-old female with Hb H disease who was initially diagnosed during adolescent pregnancy and was found to carry the -α3.7/-(α)20.5 deletions. The relatively mild presentation of this case highlights the milder phenotypic consequences of deletional α mutations. The case describes the screening and management of pregnancy with Hb H disease. Additionally, this case demonstrates that screening of some undiagnosed inherited blood disorders is important during pregnancy.
Asunto(s)
Hemoglobina H/análisis , Complicaciones Hematológicas del Embarazo/diagnóstico , Talasemia alfa/diagnóstico , Adolescente , Femenino , Eliminación de Gen , Hemoglobina H/genética , Humanos , Embarazo , Complicaciones Hematológicas del Embarazo/sangre , Complicaciones Hematológicas del Embarazo/genética , Globinas alfa/análisis , Globinas alfa/genética , Talasemia alfa/sangre , Talasemia alfa/genéticaRESUMEN
Hb Constant Spring (Hb CS) (HBA2: c.427T>C) is a common α-globin variant causing α-thalassemia (α-thal) phenotypes in mainland China. In this study, we evaluated the efficiency of erythrocyte parameters and capillary electrophoresis (CE) in the determination of Hb CS in blood samples from Hb CS carriers. Based on molecular diagnosis, there were 462 patients carrying Hb CS: 411 Hb CS heterozygotes, seven carried Hb H-Hb CS disease, 18 compound heterozygotes for Hb CS/α+-thal, and 26 double heterozygotes for Hb CS and ß-thalassemia (ß-thal). Forty-three cases had no Hb CS peak visible on CE, including all 26 cases of double heterozygotes for Hb CS and ß-thal, and 17 cases of heterozygotes carrying only Hb CS. Hb CS heterozygotes, those without a Hb CS peak, presented with lower hemoglobin (Hb), mean corpuscular volume (MCV) and mean corpuscular Hb (MCH) values than those with a Hb CS peak. The MCV <80.0 fL yielded a detection rate of 87.8% for screening individuals carrying Hb CS. Therefore, we emphasize that if one partner of a couple has tested positive for α0-thal, the other should be subjected to detailed screening for this nondeletional allele using molecular analysis, regardless of his/her red cell indices and electrophoretic chromatogram.
Asunto(s)
Hemoglobinas Anormales/genética , Globinas alfa/genética , Talasemia alfa/genética , Pueblo Asiatico/genética , China/epidemiología , Índices de Eritrocitos , Hemoglobinas Anormales/análisis , Heterocigoto , Humanos , Polimorfismo de Nucleótido Simple , Globinas alfa/análisis , Talasemia alfa/sangre , Talasemia alfa/epidemiologíaRESUMEN
ß-Thalassaemia is one of the most common monogenic diseases with no effective cure in the majority of patients. Unbalanced production of α-globin in the presence of defective synthesis of ß-globin is the primary mechanism for anaemia in ß-thalassaemia. Clinical genetic data accumulated over three decades have clearly demonstrated that direct suppression of α-globin and induction of γ-globin are effective in reducing the globin chain imbalance in erythroid cells hence improving the clinical outcome of patients with ß-thalassaemia. Here, we show that the histone deacetylase inhibitor drug, vorinostat, in addition to its beneficial effects for patients with ß-thalassaemia through induction of γ-globin, has the potential to simultaneously suppress α-globin. We further show that vorinostat exhibits these synergistic beneficial effects in globin gene expression at nanomolar concentrations without perturbing erythroid expansion, viability, differentiation or the transcriptome. This new evidence will be helpful for the interpretation of existing clinical trials and future clinical studies that are directed towards finding a cure for ß-thalassaemia using vorinostat.
Asunto(s)
Inhibidores de Histona Desacetilasas/farmacología , Vorinostat/farmacología , Globinas alfa/biosíntesis , Talasemia beta/tratamiento farmacológico , gamma-Globinas/biosíntesis , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Células Eritroides/efectos de los fármacos , Sangre Fetal/citología , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/efectos de los fármacos , Inhibidores de Histona Desacetilasas/uso terapéutico , Humanos , Análisis de Secuencia por Matrices de Oligonucleótidos , Cultivo Primario de Células , Vorinostat/uso terapéutico , Globinas alfa/análisis , Talasemia beta/sangre , gamma-Globinas/análisisRESUMEN
This is the first report of quadrupole time-of-flight (Q-TOF) mass spectrometric identification of the hemoglobin (Hb) subunits, α, ß, δ and γ peptides, derived from enzymatic-digestion of proteins in the early unknown peaks of the cation exchange chromatography of Hb. The objectives were to identify the unknown high performance liquid chromatography (HPLC) peaks in healthy subjects and in patients with ß-thalassemia (ß-thal). The results demonstrate the existence of pools of free globin chains in red blood cells (RBCs). The α-, ß-, δ- and γ-globin peptides were identified in the unknown HPLC peaks. The quantification and role of the free globin pool in patients with ß-thal requires further investigation. Identification of all types of Hb subunits in the retention time (RT) before 1 min. suggests that altered Hbs is the nature of these fast-eluting peaks. Relevancy of thalassemias to the protein-aggregation disorders will require review of the role of free globin in the pathology of the disease.
Asunto(s)
Cromatografía Líquida de Alta Presión , Subunidades de Hemoglobina/análisis , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Talasemia beta/sangre , Talasemia beta/diagnóstico , Adolescente , Adulto , Secuencia de Aminoácidos , Niño , Preescolar , Femenino , Subunidades de Hemoglobina/química , Hemoglobinas Anormales/análisis , Hemoglobinas Anormales/química , Humanos , Masculino , Adulto Joven , Globinas alfa/análisis , Globinas alfa/química , Globinas beta/análisis , Globinas beta/química , Globinas delta/análisis , Globinas delta/química , gamma-Globinas/análisis , gamma-Globinas/químicaRESUMEN
BACKGROUND: HbA1c is the standard bio-marker for glycemic control in patients with diabetes. Here, we report a α-globin chain variant and evaluate its effect on HbA1c measurements. METHODS: A 21-year-old female was suspected of harboring a hemoglobin variant following HbA1c measurement during a routine examination using Variant II Turbo 2.0 (Bio-Rad). An oral glucose tolerance test was performed using an AU5800 clinical chemistry system (Beckman Coulter). HbA1c was reanalyzed using D10 (Bio-Rad), Capillarys 2 Flex Piercing (Sebia), and Premier Hb9210 (Trinity Biotech). Hemoglobin analysis was performed using high-performance liquid chromatography (HPLC) on the Bio-Rad Variant II (ß-thalassemia short program) and capillary electrophoresis (CE, Capillarys 2 Flex Piercing, Hb program). Sanger sequencing of α and ß genes was also conducted. RESULTS: HbA1c was initially measured at 24.2% using Variant II Turbo 2.0. For the oral glucose tolerance test, fasting glucose, 1-hour, and 2-hour levels were recorded as 4.25, 7.89, and 5.34 mmol/L, respectively. Subsequently, HbA1c values determined by D10, Capillarys 2 Flex Piercing (HbA1c program), and Premier Hb9210 were 4.5% (26 mmol/mol), no HbA1c value, and 4.8 (29 mmol/mol), respectively. Hemoglobin analyzed using CE and HPLC revealed an abnormal hemoglobin. Sanger sequencing identified a transversion mutation of the α2 gene [CD16(AAG>GAG), Lys>Glu, HBA2: c.49 A>G], corresponding to a Hb I variant. CONCLUSION: An unusually high HbA1c or discordance between blood sugar and HbA1c values should alert about the possibilities of hemoglobin variants.
Asunto(s)
Hemoglobina Glucada/química , Hemoglobina Glucada/genética , Hemoglobinas Anormales/química , Hemoglobinas Anormales/genética , Globinas alfa/química , Globinas alfa/genética , Adulto , Glucemia , Análisis Mutacional de ADN , Femenino , Prueba de Tolerancia a la Glucosa , Hemoglobina Glucada/análisis , Hemoglobinas Anormales/análisis , Humanos , Mutación/genética , Adulto Joven , Globinas alfa/análisisRESUMEN
OBJECTIVE: The objective of this study is to identify potential CpG site(s) or DNA methylation pattern(s) in the pseudo α-globin 1 gene (HBAP1 gene), the gene which locates in α-thalassemia-1 deletion mutation, to differentiate plasma DNA between pregnant and non-pregnant women. METHOD: DNA methylation profiles of placenta and peripheral blood from the MethBase database were compared to screen differentially methylated regions. This region was confirmed the differential by methylation-sensitive high resolution melt (MS-HRM) analysis. The differential region was used to compare DNA methylation profile of plasma DNA between pregnant and non-pregnant women by bisulfite amplicon sequencing in three levels: overall, individual CpG sites and individual molecules (DNA methylation patterns). RESULT: Using MethBase data, four consecutive CpG sites in the HBAP1 gene were identified as regions of differential DNA methylation between placenta and peripheral blood. The confirmation by MS-HRM showed the differential DNA methylation profile between the placenta and plasma from non-pregnant women. The comparison of DNA methylation profiles between the plasma of pregnant and non-pregnant women showed that, in the overall levels of the four CpG sites, DNA methylation of pregnant women was detected at lower levels than non-pregnant women. In the individual CpG site level, only the second CpG site showed differential DNA methylation between the groups. In the DNA methylation pattern level, there was no strongly significant differences in DNA methylation patterns between the pregnant and non-pregnant groups. CONCLUSION: Our result demonstrated that, in the plasma from pregnant women, only one of the four CpG sites displays a decrease in DNA methylation compared with non-pregnant women. It indicates that this CpG site might be useful for determining the presence or absence of fetal wild-type α-globin gene cluster allele in maternal plasma.
Asunto(s)
Metilación de ADN , ADN/sangre , Epigénesis Genética , Placenta/metabolismo , Globinas alfa/genética , Islas de CpG , ADN/genética , Femenino , Humanos , Embarazo , Regiones Promotoras Genéticas , Análisis de Secuencia de ADN , Globinas alfa/análisisRESUMEN
Traditional methods for thalassemia screening are time-consuming and easily affected by cell hemolysis or hemoglobin degradation in stored blood samples. Tandem mass spectrometry (MS/MS) proved to be an effective technology for sickle cell disorders (SCD) screening. Here, we developed a novel MS/MS method for ß-thalassemia screening from dried blood spots (DBS). Stable isotopic-labeled peptides were used as internal standards for quantification and calculation of the α:ß-globin ratios. We used the α:ß-globin ratio cutoffs to differentiate between normal individuals and patients with thalassemia. About 781 patients and 300 normal individuals were analyzed. The α:ß-globin ratios showed significant difference between normal and ß-thalassemia patients (P<0.01), particularly when the disease was homozygous or double heterozygous with another α- or ß-thalassemia mutation. In the parallel study, all cases screened for suspected thalassemia from six hundred DBS samples by using this MS/MS method were successfully confirmed by genotyping. The intra-assay and inter-assay CVs of the ratios ranged from 2.4% to 3.9% and 4.7% to 7.1%, and there was no significant sample carryover or matrix effect for this MS/MS method. Combined with SCD screening, this MS/MS method could be used as a first-line screening assay for both structural and expression abnormalities of human hemoglobin. BIOLOGICAL SIGNIFICANCE: Traditional methods for thalassemia screening were depending on the structural integrity of tetramers and could be affected by hemolysis and degradation of whole blood samples, especially when stored. We used proteospecific peptides produced by the tryptic digestion of each globin to evaluate the production ratio between α- and ß-globin chains, which turned out to be quite stable even when stored for more than two months. Though most of the peptides were specific to α-globin or ß-globin, we only chose four most informative peptides and its stable isotopic-labeled peptides as internal standards for analysis, which could obtain a high accuracy. Currently, we are the first to address the application of MS/MS for thalassemia screening, when combined with SCD screening, this MS/MS method could be used as a first-line screening assay for both structural and expression abnormalities of human hemoglobin.
Asunto(s)
Espectrometría de Masas en Tándem/métodos , Talasemia beta/diagnóstico , Recolección de Muestras de Sangre/métodos , Estudios de Casos y Controles , Genotipo , Humanos , Tamizaje Masivo/métodos , Sensibilidad y Especificidad , Globinas alfa/análisis , Globinas beta/análisis , Talasemia beta/sangreRESUMEN
BACKGROUND: Alpha-thalassaemia is an autosomal recessive disorder characterized by defective production of the alpha chain of haemoglobin. It is caused mainly by deletions of one or both of the duplicated alpha-globin genes on chromosome 16, and/or by nucleotide variations, known as "nondeletion" mutations. Definition of the alpha globin genotype in carriers supports genetic counselling, and in patients with Hb H disease is useful to predict prognosis and management options. Here, we report a method that facilitates direct detection by naked eye of the 13 most common "nondeletion" alpha-globin gene mutations in populations around the Mediterranean and Middle East. METHODS AND RESULTS: The method comprises (i) PCR amplification of a single 1087 bp fragment for each HBA1 and HBA2 gene (separately); (ii) multiplex primer extension reaction of just 10 cycles, using unpurified amplification product as a template, to incorporate biotin into those allele-specific primers that extend and, finally, (iii) visual detection of the reaction products within minutes by the dipstick biosensor. The method was evaluated by analysing 105 samples of known genotypes and the results were found fully concordant with those obtained by the reference methods. CONCLUSIONS: The proposed assay is particularly suited for small molecular-diagnostic laboratories with a limited budget and a low-to-medium sample volume. In addition this platform represents a very simple and useful genotyping tool to support gene scanning methods whenever nucleotide variations have to be specified.
Asunto(s)
Técnicas Biosensibles/métodos , Hemoglobina Glucada/genética , Hemoglobina A2/genética , Reacción en Cadena de la Polimerasa Multiplex/métodos , Globinas alfa/genética , Talasemia alfa/diagnóstico , Técnicas Biosensibles/economía , Cartilla de ADN/síntesis química , Cartilla de ADN/genética , Expresión Génica , Pruebas Genéticas , Genotipo , Humanos , Región Mediterránea , Sensibilidad y Especificidad , Globinas alfa/análisis , Talasemia alfa/genéticaRESUMEN
Clinical severity assessment and molecular analysis of ß-, α-globin genes and the -158 (C > T) XmnI polymorphism of the (G)γ-globin gene were performed in 80 pediatric patients with Hb E (HBB: c.79G > A)/ß-thalassemia (ß-thal) to investigate the effects of coinheritance of α-thalassemia (α-thal) and other molecular determinants on their clinical severity. The mean age was 9.4 ± 5.1 years. By using clinical severity score, 35 (43.8%), 27 (33.8%) and 18 cases (22.5%) had moderate, mild and severe disease, respectively. Nine ß-thal mutations were identified. All were ß° or severe ß⺠mutations. Five patients (6.3%) had coinherited α°-thal. All five patients had mild disease with baseline hemoglobin (Hb) values of 7.9 ± 1.5 g/dL, mild hepatosplenomegaly and close-to-normal growth. Only one required a red blood cell transfusion. The disease severity was significantly different among the groups with and without α-thal (p = 0.025), but was not different among the groups with or without the XmnI polymorphism (p = 0.071). This study demonstrates that coinheritance of α°-thal alleviates the degree of disease severity in Hb E/ß-thal. All our patients with coinherited α°-thal have mild disease.
Asunto(s)
Hemoglobina E/genética , Mutación , Polimorfismo Genético , Globinas alfa/genética , Talasemia alfa/genética , Talasemia beta/genética , gamma-Globinas/genética , Adolescente , Niño , Preescolar , Codón , Desoxirribonucleasas de Localización Especificada Tipo II/metabolismo , Femenino , Estudios de Asociación Genética , Hemoglobina E/análisis , Hemoglobina E/metabolismo , Humanos , Lactante , Intrones , Masculino , Mutación Puntual , Polimorfismo de Longitud del Fragmento de Restricción , Estudios Retrospectivos , Eliminación de Secuencia , Índice de Severidad de la Enfermedad , Tailandia , Globinas alfa/análisis , Globinas alfa/metabolismo , Talasemia alfa/sangre , Talasemia alfa/complicaciones , Talasemia beta/sangre , Talasemia beta/complicaciones , Talasemia beta/fisiopatología , gamma-Globinas/análisis , gamma-Globinas/metabolismoRESUMEN
INTRODUCTION: High-performance liquid chromatography (HPLC) is a method commonly used for the detection of hemoglobin (Hb) variants. In addition to providing precise quantitation of Hb A2 and Hb F, the reported retention time and peak shape of a high number of hemoglobin (Hb) variants are very helpful for presumptive identification. However, there is a scarcity of summarized data in the literature of the mobility of Hb variants on this method. METHODS: A total of 383 Hb variants were studied on the Bio-Rad Variant (™) Classic HPLC instrument. Hb variant identification used a number of methods, including confirmation by DNA sequencing in at least one case for all alpha and beta chain Hb variants. RESULTS: Retention time data and the number of occurrences of each Hb variant were obtained. This showed that rare Hb variants can have similar retention times to the five most common alpha or beta chain Hb variants. CONCLUSION: HPLC is a very powerful tool in the evaluation of Hb variants, particularly when combined with other methods. However, it should not be used as a stand-alone method for definitive identification of Hb variants.
Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Hemoglobinas Anormales/análisis , Globinas alfa/análisis , Globinas beta/análisis , Variación Genética , Hemoglobinas Anormales/genética , Humanos , Reproducibilidad de los Resultados , Análisis de Secuencia de ADN , Globinas alfa/genética , Globinas beta/genéticaRESUMEN
OBJECTIVES: To evaluate the relationship between FAST peak percentage by adapted Bio-Rad Vnbs analysis using the valley-to-valley integration and genotypes with the aim to improve differentiation between severe α-thalassaemia forms (HbH disease) and the milder disease types. METHOD: DNA analysis for α-thalassaemia was performed on 91 dried blood spot samples presenting normal and elevated FAST peak levels, selected during three years of Dutch national newborn screening. RESULTS: Significant differences were found between samples with and without α-thalassaemia mutations, regardless of the genetic profiles. No significant difference was demonstrated between HPLC in -α/αα and -α/-α, between -α/-α and - -/αα and between - -/αα and - -/-α genotypes. CONCLUSION: This study confirms that the percentage HbBart's, as depicted by the FAST peak, is only a relative indication for the number of α genes affected in α-thalassaemia. Based on the data obtained using the modified Bio-Rad Vnbs software, we adopted a cut-off value of 22.5% to discriminate between possible severe α-thalassaemia or HbH disease and other α-thalassaemia phenotypes. Retrospectively, if this cut-off value was utilized during this initial three-year period of neonatal screening, the positive predictive value would have been 0.030 instead of 0.014.
Asunto(s)
Pruebas Genéticas/métodos , Mutación , Tamizaje Neonatal/métodos , Talasemia alfa/diagnóstico , Talasemia alfa/genética , Análisis Químico de la Sangre/métodos , Cromatografía Líquida de Alta Presión , Análisis Mutacional de ADN , Sangre Fetal/química , Hemoglobina H/análisis , Hemoglobina H/genética , Hemoglobinas Anormales/análisis , Hemoglobinas Anormales/genética , Heterocigoto , Homocigoto , Humanos , Recién Nacido , Países Bajos , Estudios Retrospectivos , Globinas alfa/análisis , Globinas alfa/genética , Talasemia alfa/sangreAsunto(s)
Hemoglobina E/metabolismo , Hemoglobinopatías/diagnóstico , Hemoglobinas Anormales/metabolismo , Adolescente , Adulto , Cromatografía por Intercambio Iónico , Femenino , Eliminación de Gen , Hemoglobina E/análisis , Hemoglobina E/aislamiento & purificación , Hemoglobina Falciforme/análisis , Hemoglobina Falciforme/aislamiento & purificación , Hemoglobina Falciforme/metabolismo , Hemoglobinopatías/sangre , Hemoglobinopatías/genética , Hemoglobinas Anormales/análisis , Hemoglobinas Anormales/aislamiento & purificación , Heterocigoto , Humanos , India , Masculino , Adulto Joven , Globinas alfa/análisis , Globinas alfa/genética , Talasemia beta/sangre , Talasemia beta/diagnóstico , Talasemia beta/genéticaRESUMEN
PURPOSE: The purpose of this study was to identify protein markers present in subjects with temporomandibular joint disorders (TMDs) and clicking compared with the levels in controls. MATERIALS AND METHODS: This was a pilot case-control study, and we report the preliminary results. Samples of joint aspirate collected from patients with TMDs and controls who had undergone surgery for a problem other than TMDs were analyzed using isobaric tags for relative and absolute quantitation (iTRAQ) and biotin-labeled-based protein arrays. The data obtained from these techniques were used to identify the proteins of interest, which were then quantitated using enzyme-linked immunosorbent assay (ELISA). The patient samples studied included joint aspirate collected clinically from the controls and patients and included samples from both the right and the left sides of each patient with a TMD. RESULTS: The 8 TMJ aspirate samples from 6 subjects included 5 aspirate samples from 4 patients and 3 from 2 controls. The greatest standardized protein concentration of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 (EG-VEGF/PK1) and D6 was found in both joints of the controls compared with the levels from the joints of the patients. With 1 exception, the standardized protein concentration was significantly lower in the patients than in the controls. The lower levels of EG-VEGF/PK1 and D6 in the patients compared with the controls suggest that these cytokines might be possible biomarkers for TMDs. CONCLUSION: In the present pilot study, greater levels of EG-VEGF/PK1 and D6 were found in the controls than in the patients with TMDs. Proteomic analysis of the proteins present in the diseased joints compared with those in the controls might help to identify proteins present when pain or degeneration of the joint occurs. The proteomic information might be useful in the development of future therapies.
Asunto(s)
Biomarcadores/análisis , Proteoma/análisis , Trastornos de la Articulación Temporomandibular/diagnóstico , Activinas/análisis , Adolescente , Adulto , Anhidrasas Carbónicas/análisis , Estudios de Casos y Controles , Quimiocina CCL21/análisis , Femenino , Humanos , Factor II del Crecimiento Similar a la Insulina/análisis , Luxaciones Articulares/diagnóstico , Luxaciones Articulares/metabolismo , Metaloproteinasa 16 de la Matriz/análisis , Paracentesis , Peroxirredoxinas/análisis , Proyectos Piloto , Análisis por Matrices de Proteínas , Receptores CCR10/análisis , Líquido Sinovial/química , Disco de la Articulación Temporomandibular/patología , Trastornos de la Articulación Temporomandibular/metabolismo , Factor de Crecimiento Endotelial Vascular Derivado de Glándula Endocrina/análisis , Adulto Joven , Globinas alfa/análisis , Globinas beta/análisis , gamma-Globinas/análisis , Receptor de Quimiocina D6RESUMEN
Sarcoplasmic proteins isolated from bovine livers were hydrolyzed using the enzyme thermolysin at 37°C for 2h. The hydrolyzates were filtered through molecular weight cut off membranes (MWCO) and filtrates were obtained. The water activity (a(w)) of unhydrolysed sarcoplasmic protein, full hydrolyzates, 10-kDa and 3-kDa filtrates were below the limit necessary for microbial growth. The antioxidant activities of both filtrates and fractions were assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity assay, the ferric ion reducing antioxidant power (FRAP) assay and the Fe(2+) chelating ability assay. RP-HPLC was used for purification of the full hydrolyzates, the 10-kDa and the 3-kDa filtrates. The peptidic content of the full hydrolyzates, the 10-kDa and the 3-kDa filtrates were assessed using the Dumas method and peptide contents of each fraction were characterized using electrospray quadrupole time-of-flight (ESI-Q-TOF) mass spectrometry with the resultant spectrum analysed using the software programmes Protein Lynx Global Server 2.4. and TurboSEQUEST. Similarities between the amino acid composition of characterized peptides from each fraction and previously reported antioxidant peptides were found. This study demonstrates that meat by-product such as liver can be utilised as raw material for the generation of bioactive peptides with demonstrated antioxidant activities in vitro using the enzyme thermolysin. It is significant as it presents a potential opportunity for meat processors to use their waste streams for the generation of bioactive peptides for potential functional food use.